H. Evin Gulbahce

1.3k citations
63 papers · 928 indexed · h-index 20
Topics
HER2/EGFR in Cancer Research (13 papers)Breast Cancer Treatment Studies (12 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)
Partner nations
United States

In The Last Decade

H. Evin Gulbahce

62 papers receiving 904 citations

Peers

H. Evin Gulbahce
Comparison fields: 5 of 81
  • Epidemiology 377
  • Oncology 364
  • Surgery 234
  • Pulmonary and Respiratory Medicine 228
  • Hematology 133
Replace Hiroyuki Ochi with:
Hiroyuki Ochi Japan
Hans Bösmüller Germany
Roberta Schiavo Italy
Marco Marziali Italy
M Baratz Israel
Christoph Kahl Germany
Miriam Mints Sweden
Noemi Corbetta Italy
Ulrich Duffner United States
Shehnaz K. Hussain United States
H. Evin Gulbahce relative to Hiroyuki Ochi Japan Hiroyuki Ochi's profile →
Citations per field
00.5×2.6×
Hiroyuki Ochi · 1×
Citations per year

Countries citing papers authored by H. Evin Gulbahce

Since Specialization
Citations

This map shows the geographic impact of H. Evin Gulbahce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Evin Gulbahce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Evin Gulbahce more than expected).

Fields of papers citing papers by H. Evin Gulbahce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Evin Gulbahce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Evin Gulbahce. The network helps show where H. Evin Gulbahce may publish in the future.

Co-authorship network of co-authors of H. Evin Gulbahce

This figure shows the co-authorship network connecting the top 25 collaborators of H. Evin Gulbahce. A scholar is included among the top collaborators of H. Evin Gulbahce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Evin Gulbahce. H. Evin Gulbahce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 2
5 1
6 5
7 27
8 5
9 13
10 10
11 20
12 24
13 24
14 30
15 17
16 34
17 4
18 9
19 19
20 3

About H. Evin Gulbahce

H. Evin Gulbahce is a scholar working on Oncology, Cancer Research and Microbiology, having authored 63 papers that have together received 928 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Oncology (364 citations), Transplantation (34 citations) and Hematology (133 citations). H. Evin Gulbahce has collaborated with scholars based in United States. Frequent co-authors include Stefan E. Pambuccian, José Jessurun, J. Carlos Manivel, Kay Savik, Deniz Aslan, Alan G. Rose, Mariam Alsharif, Charlotte A. Brown, Carol Sweeney and Edward B. Stelow. Their work appears in journals such as Cancer, The American Journal of Surgical Pathology and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026